Industry Overview

India animal vaccine market was valued at $473.8 million in 2025 and is projected to reach $1,144.7 million by 2035, growing at a CAGR of 9.2% during the forecast period (2026–2035). The India animal vaccine market is witnessing steady expansion, supported by the country’s large livestock population, increasing demand for animal protein, and strengthened government focus on disease prevention and food security. With India being one of the world’s leading producers of milk, poultry, and aquaculture products, preventive animal healthcare has become a strategic priority to minimize economic losses caused by infectious diseases. Government-led immunization programs targeting diseases such as foot-and-mouth disease (FMD), brucellosis, and classical swine fever are significantly driving vaccine adoption across rural and semi-urban regions. Initiatives under the Department of Animal Husbandry & Dairying, including nationwide livestock vaccination campaigns, are reinforcing structured disease control frameworks.

Technological advancements in recombinant and DNA-based vaccines, coupled with growing private sector participation, are enhancing vaccine efficacy, safety, and scalability. Additionally, the expansion of cold-chain infrastructure and veterinary healthcare networks is improving vaccine accessibility across states. As India continues to modernize its livestock management practices and strengthen biosecurity measures, animal vaccines are playing a critical role in improving productivity, export potential, and long-term animal health sustainability.

Market Dynamics

Rising Government-Sponsored Livestock Immunization Programs

India has intensified its national animal disease control efforts through large-scale vaccination drives. Programs targeting FMD and brucellosis aim to improve livestock productivity and reduce economic losses for farmers. Increased public funding, free vaccination campaigns, and awareness initiatives are contributing to higher vaccine penetration rates, particularly in cattle and buffalo populations. Growing emphasis on disease surveillance and preventive healthcare is further strengthening demand for both traditional and advanced vaccine formulations across states.

Expansion of Commercial Poultry and Aquaculture Sectors

The rapid growth of India’s poultry and aquaculture industries is creating sustained demand for preventive vaccination solutions. Intensive farming practices increase susceptibility to infectious outbreaks, making routine vaccination essential for maintaining productivity and export standards. Rising consumption of poultry meat, eggs, and fish, along with expanding contract farming models, is encouraging farmers to adopt structured vaccination schedules. As biosecurity standards tighten, vaccine manufacturers are witnessing increased demand for targeted and combination vaccines.

Market Segmentation

• Based on the type, the market is segmented into porcine vaccines, poultry vaccines, livestock vaccines, aquaculture vaccines, companion animal vaccines, and other animal vaccines.
• Based on the technology, the market is segmented into live attenuated vaccine, killed/inactive vaccine, recombinant vaccine, vectored vaccine, subunit vaccine, DNA vaccine, chimeric vaccine, and others.

Livestock Vaccines Segment to Lead the Market with the Largest Share

The livestock vaccines segment is expected to account for the largest share of the India animal vaccine market, primarily driven by the country’s extensive cattle and buffalo population. National immunization campaigns against FMD, brucellosis, and other endemic diseases are significantly boosting vaccine volumes. Increased dairy production targets, rural livelihood dependence on livestock, and government subsidies for vaccination programs are reinforcing segment growth. Furthermore, improved disease monitoring systems and expansion of veterinary outreach services are enhancing adoption rates across states. As India continues to prioritize dairy and livestock productivity, this segment is projected to maintain market leadership.

Live Attenuated and Inactivated Vaccines Dominate Technology Landscape

Live attenuated and killed/inactivated vaccines currently represent the dominant technologies in India’s animal vaccine market due to their established efficacy, affordability, and widespread availability. These vaccines are extensively used in mass immunization programs because of their suitability for large-scale deployment. However, recombinant and DNA vaccines are gaining traction as research institutions and biotechnology companies focus on improving safety profiles and long-term immunity.

Market Players Outlook

The major companies operating in the India animal vaccine market include Hester Biosciences Limited, Indian Immunologicals Limited, Sequent Scientific Limited, Venky's (India) Limited, Zoetis India Limited., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In July 2025, Indian Immunologicals Limited expanded its livestock vaccine production capacity to support nationwide FMD and brucellosis immunization programs, strengthening domestic supply capabilities.
• In May 2025, Zoetis Inc. enhanced its companion animal vaccine portfolio in India with advanced recombinant solutions aimed at improving preventive care standards in urban veterinary clinics.
• In April 2025, Hester Biosciences Limited announced the expansion of its poultry vaccine manufacturing facilities to meet rising domestic and export demand.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the India animal vaccine
• Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.